SAM
ANAB icon

Smartleaf Asset Management’s AnaptysBio ANAB Stock Holding History

Smartleaf Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.4K Hold
840
– – ﹤0.01% 1464
2026
Q1 		$46.5K Buy
840
+5
+0.6% +$269 ﹤0.01% 1493
2025
Q4 		$40.3K Buy
835
+821
+5,864% +$32K ﹤0.01% 1657
2025
Q3 		$325 Hold
14
– – ﹤0.01% 2908
2025
Q2 		$314 Sell
14
-6
-30% -$126 ﹤0.01% 2634
2025
Q1 		$379 Sell
20
-81
-80% -$1.35K ﹤0.01% 2736
2024
Q4 		$1.33K Buy
101
+12
+13% +$291 ﹤0.01% 2623
2024
Q3 		$2.84K Hold
89
– – ﹤0.01% 2362
2024
Q2 		$2.21K Buy
+89
New +$2.07K ﹤0.01% 2192

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Smartleaf Asset Management's ANAB Position: Q2 2026 in Review

Smartleaf Asset Management held its AnaptysBio (ANAB) position steady in Q2 2026 at 840 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Smartleaf Asset Management first reported a position in ANAB in Q2 2024 and has held it in 9 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Smartleaf Asset Management held 840 shares of AnaptysBio worth $55.4K as of Q2 2026.
  • Smartleaf Asset Management left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1464 holding.
  • Smartleaf Asset Management first reported a position in AnaptysBio in Q2 2024 and has held it in 9 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.